FACTANKER · measured, cited, anchored official records connected

NORTHWEST BIOTHERAPEUTICS INC — Revenue by Fiscal Year

16 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/70ce430e-5b88-47f0-aaa7-056dcf84041b/serie/revenue

Fiscal yearRevenuePeriodEvidence
FY 2025$1.4M2025-01-01 – 2025-12-31evidence 0001104659-26-043806
FY 2024$1.4M2024-01-01 – 2024-12-31evidence 0001410578-25-000598
FY 2023$1.9M2023-01-01 – 2023-12-31evidence 0001410578-25-000598
FY 2022$1.7M2022-01-01 – 2022-12-31evidence 0001410578-23-000185
FY 2021$1.0M2021-01-01 – 2021-12-31evidence 0001410578-22-000244
FY 2020$1.3M2020-01-01 – 2020-12-31evidence 0001104659-21-044832
FY 2019$2.4M2019-01-01 – 2019-12-31evidence 0001104659-20-034145
FY 2018$412.0k2018-01-01 – 2018-12-31evidence 0001144204-19-017803
FY 2017$336.0k2017-01-01 – 2017-12-31evidence 0001144204-19-017803
FY 2016$623.0k2016-01-01 – 2016-12-31evidence 0001144204-17-020754
FY 2015$1.7M2015-01-01 – 2015-12-31evidence 0001144204-16-088301
FY 2014$1.5M2014-01-01 – 2014-12-31evidence 0001144204-15-016579
FY 2013$4.3M1996-03-18 – 2014-03-31evidence 0001144204-14-031414
FY 2012$3.7M1996-03-18 – 2013-03-31evidence 0001144204-13-029641
FY 2011$2.8M1996-03-18 – 2012-03-31evidence 0001144204-12-030833
FY 2010$10.0k2010-01-01 – 2010-12-31evidence 0001144204-12-021574
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

NORTHWEST BIOTHERAPEUTICS INC — all facts · Net Income · Operating Income